Clinical Trial Update: Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Avelumab in combination with AVB-S6-500 in patients with advanced urothelial carcinoma; current status is active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• AVB-S6-500
• Avelumab (avelumab)

Snippet

Sponsor: University of Oklahoma | Conditions: Urothelial Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING